Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication.
Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.
Kaiser Permanente research published in JAMA Cardiology identifies national trend linked to aging of baby boomers and upturn in heart disease mortality.
Kaiser Permanente research found diabetes occurred 3 times more often among normal-BMI Native Hawaiians and Pacific Islanders than normal-BMI whites.
An algorithm developed by Kaiser Permanente researchers in Northern California could refer more at-risk patients for the preventive medication PrEP.
A study published in Annals of Internal Medicine found 9 out of 10 Kaiser Permanente members using primary care video visits were confident about the quality of care they received.
Kaiser Permanente researchers and Permanente physicians write in a JAMA Pediatrics editorial about the need to overcome barriers to screening and preventive interventions.
A study looking at a program helping patients quit smoking around the time of their surgery shows initial results are promising.